Vetsys Pharmaceutical
The global biosurfactants market is currently undergoing a paradigm shift, transitioning from conventional synthetic surfactants to bio-based, biodegradable, and eco-friendly alternatives. Biosurfactants, which include rhamnolipids, sophorolipids, and surfactants derived from microbial fermentation, are gaining immense popularity across various sectors, including pharmaceuticals, personal care, agriculture, and oil recovery.
In the current industrial landscape, the demand for biosurfactants is driven by stringent environmental regulations and a growing consumer preference for sustainable products. Unlike chemical surfactants derived from petroleum, biosurfactants offer lower toxicity and higher biodegradability, making them the preferred choice for forward-thinking industries. As leading China biosurfactants manufacturers, companies like Zhengzhou Vetsys are at the heart of this transformation, bridging the gap between high-performance chemical requirements and environmental stewardship.
Expected to reach over USD 2.5 billion by 2030, with a CAGR exceeding 5.5% globally.
Global corporations are prioritizing biosurfactants to meet their Environmental, Social, and Governance goals.
Advancements in fermentation technology are reducing production costs, making biosurfactants more competitive.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, stands as a premier pillar in the animal pharmaceutical and chemical manufacturing landscape. With a robust registered capital of 30 million RMB, Vetsys has evolved from a local manufacturer into a sophisticated enterprise serving both domestic and international markets. Our facilities are designed to handle complex production lines, ensuring that every batch of product meets the rigorous demands of the modern industrial sector.
Vetsys operates in strict compliance with Good Manufacturing Practices (GMP). This commitment to quality has allowed us to achieve annual sales exceeding USD 20 million by 2015 in the domestic market alone. As we expand our horizon into the biosurfactant sector, our core expertise in pharmaceutical chemistry provides us with a unique advantage in producing high-purity, bio-active agents for animal health and industrial applications.
At Vetsys, we distinguish ourselves by placing a relentless emphasis on technological development. Innovation is not just a buzzword for us; it is the engine that drives our research institute. Equipped with five specialized laboratories and staffed by a team of world-class scientists, we focus on the synthesis of bioactive compounds and the stabilization of surfactant-based formulations.
This scientific infrastructure enables us to adapt quickly to global market demands. Whether it's developing new antibacterial delivery systems or optimizing the solubility of complex medicines through surfactant technology, Vetsys remains at the forefront. Our commitment to research ensures that we continuously enhance our product offerings, contributing significantly to advancements in both animal healthcare and bio-chemical engineering.
Our five laboratories focus on everything from pharmaceutical synthesis to microbiological testing.
Collaborating with world-class scientists to maintain a competitive edge in global markets.
Rapid prototyping and production scaling to meet the shifting needs of international buyers.
Vetsys utilizes state-of-the-art machinery to ensure precision and quality. From injection molding to automated assembly, our factory is a testament to China's manufacturing prowess.











The global procurement demand for biosurfactants and advanced pharmaceutical additives is reaching new heights. International buyers are looking for suppliers who can provide not just products, but reliability, regulatory compliance, and a stable supply chain. As a leading factory in China, Vetsys meets these requirements through our extensive manufacturing capabilities, including workshops for powders, premixes, injections, and herbal drug extracts.
One of the key trends in the industry is the application of biosurfactants in localized application scenarios. For instance, in agriculture, they are used to enhance the efficacy of bio-pesticides; in animal health, they act as powerful emulsifiers for vitamin and antibiotic delivery systems. The move toward "Green Chemistry" is no longer optional—it is a market necessity.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation and sustainable practices. Our future strategy includes deepening our international expansion through strategic partnerships and research collaborations. We aim to bring high-quality, innovative health solutions to global markets, ensuring that the Vetsys brand remains synonymous with reliability and excellence in the biosurfactant and pharmaceutical industries.